SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040555
Filing Date
2023-11-13
Accepted
2023-11-13 16:34:38
Documents
20
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47909
2 ex99-1.htm EX-99.1 149642
3 ex99-2.htm EX-99.2 169041
4 ex99-1_001.jpg GRAPHIC 9231
5 ex99-2_001.jpg GRAPHIC 3434
6 ex99-2_002.jpg GRAPHIC 22941
7 ex99-2_003.jpg GRAPHIC 56212
8 ex99-2_004.jpg GRAPHIC 29177
  Complete submission text file 0001493152-23-040555.txt   802562

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hrow-20231113.xsd EX-101.SCH 3944
10 XBRL DEFINITION FILE hrow-20231113_def.xml EX-101.DEF 27404
11 XBRL LABEL FILE hrow-20231113_lab.xml EX-101.LAB 37859
12 XBRL PRESENTATION FILE hrow-20231113_pre.xml EX-101.PRE 26021
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6232
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 231399438
SIC: 2834 Pharmaceutical Preparations